Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial.

El-Serag HB, Lee P, Buchner A, Inadomi JM, Gavin M, McCarthy DM.

Am J Gastroenterol. 2001 Apr;96(4):979-83.

2.

Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.

Williams RB, Szczesniak MM, Maclean JC, Brake HM, Cole IE, Cook IJ.

Am J Gastroenterol. 2004 May;99(5):777-85.

PMID:
15128336
4.

Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study.

Noordzij JP, Khidr A, Evans BA, Desper E, Mittal RK, Reibel JF, Levine PA.

Laryngoscope. 2001 Dec;111(12):2147-51.

PMID:
11802014
5.

Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.

Castell DO, Richter JE, Robinson M, Sontag SJ, Haber MM.

Am J Gastroenterol. 1996 Sep;91(9):1749-57.

PMID:
8792693
6.

Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.

Wo JM, Grist WJ, Gussack G, Delgaudio JM, Waring JP.

Am J Gastroenterol. 1997 Dec;92(12):2160-5.

PMID:
9399745
7.

Efficacy of low-dose lansoprazole in the treatment of non-erosive gastrooesophageal reflux disease. Influence of infection by Helicobacter pylori.

Castro Fernández M, García Díaz E, Larraona JL, Rodríguez Hornillo MC, Lamas Rojas E, Núñez Hospital D, Pallarés Querol M.

Rev Esp Enferm Dig. 2006 Mar;98(3):170-9. English, Spanish.

8.

Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.

Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ.

Am J Med. 2004 Jun 1;116(11):740-8.

PMID:
15144910
9.

Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy.

Qua CS, Wong CH, Gopala K, Goh KL.

Aliment Pharmacol Ther. 2007 Feb 1;25(3):287-95.

10.

Omeprazole as a diagnostic tool in gastroesophageal reflux disease.

Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Festen HP, Jansen EH, Tuynman HA, Schrijver M, Dieleman LA, Meuwissen SG.

Am J Gastroenterol. 1997 Nov;92(11):1997-2000.

PMID:
9362179
11.

Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.

Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Haber M.

Am J Gastroenterol. 1996 Sep;91(9):1758-65.

PMID:
8792694
12.

Omeprazole for the treatment of posterior laryngitis.

Kamel PL, Hanson D, Kahrilas PJ.

Am J Med. 1994 Apr;96(4):321-6.

PMID:
8166150
13.
14.

Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole.

Graham DY, Agrawal NM, Campbell DR, Haber MM, Collis C, Lukasik NL, Huang B; NSAID-Associated Gastric Ulcer Prevention Study Group.

Arch Intern Med. 2002 Jan 28;162(2):169-75.

PMID:
11802750
15.
16.

Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study.

Eherer AJ, Habermann W, Hammer HF, Kiesler K, Friedrich G, Krejs GJ.

Scand J Gastroenterol. 2003 May;38(5):462-7.

PMID:
12795454
17.

Diagnostic test with omeprazole in patients with posterior laryngitis.

Siupsinskiene N, Adamonis K.

Medicina (Kaunas). 2003;39(1):47-55.

18.

Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children.

Tolia V, Ferry G, Gunasekaran T, Huang B, Keith R, Book L.

J Pediatr Gastroenterol Nutr. 2002;35 Suppl 4:S308-18.

PMID:
12607791
19.

Proximal esophageal pH-metry in patients with 'reflux laryngitis'.

Jacob P, Kahrilas PJ, Herzon G.

Gastroenterology. 1991 Feb;100(2):305-10.

PMID:
1985028
20.

Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain.

Xia HH, Lai KC, Lam SK, Hu WH, Wong NY, Hui WM, Lau CP, Chen WH, Chan CK, Wong WM, Wong BC.

Aliment Pharmacol Ther. 2003 Feb;17(3):369-77.

Supplemental Content

Support Center